{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:38:59Z","timestamp":1790991539557,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"MIUR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["14204"],"award-info":[{"award-number":["14204"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["16776"],"award-info":[{"award-number":["16776"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006747","name":"Fondazione Cariverona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006747","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Verona Nanomedicine Initiative"},{"name":"Italian Minister of Health","award":["RF-2010-2305526"],"award-info":[{"award-number":["RF-2010-2305526"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jconrel.2016.08.010","type":"journal-article","created":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T14:04:27Z","timestamp":1471010667000},"page":"10-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness"],"prefix":"10.1016","volume":"239","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3024-0307","authenticated-orcid":false,"given":"Giulio","family":"Fracasso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Falvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Colotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziano","family":"Ingegnere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Amalfitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Battista","family":"Doglietto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Boffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Morea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giamaica","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Tremante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizio","family":"Giacomini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Arcovito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7712-8430","authenticated-orcid":false,"given":"Pierpaolo","family":"Ceci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.08.010_bb0005","doi-asserted-by":"crossref","first-page":"12278","DOI":"10.1039\/c3nr04268e","article-title":"Antibody-drug conjugates: targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin","volume":"5","author":"Falvo","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2016.08.010_bb0010","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1021\/nn305791q","article-title":"RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors","volume":"7","author":"Zhen","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.08.010_bb0015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nnano.2012.90","article-title":"Magnetoferritin nanoparticles for targeting and visualizing tumour tissues","volume":"7","author":"Fan","year":"2012","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2016.08.010_bb0020","first-page":"1489","article-title":"Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles","volume":"7","author":"Vannucci","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2016.08.010_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1166\/jbn.2015.1946","article-title":"In vivo targeting of cutaneous melanoma using an melanoma stimulating hormone-engineered human protein cage with fluorophore and magnetic resonance imaging tracers","volume":"11","author":"Vannucci","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.jconrel.2016.08.010_bb0030","doi-asserted-by":"crossref","first-page":"14900","DOI":"10.1073\/pnas.1407808111","article-title":"H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection","volume":"111","author":"Liang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.08.010_bb0035","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jconrel.2014.10.002","article-title":"Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in cancer cells","volume":"196","author":"Bellini","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.08.010_bb0040","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.2217\/nnm.14.119","article-title":"Apoferritin applications in nanomedicine","volume":"9","author":"Heger","year":"2014","journal-title":"Nanomedicine-UK"},{"key":"10.1016\/j.jconrel.2016.08.010_bb0045","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1021\/acs.biomac.5b00435","article-title":"Supramolecular assembly and coalescence of ferritin cages driven by designed protein\u2013protein interactions","volume":"16","author":"Bellapadrona","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2016.08.010_bb0050","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1021\/bm301339s","article-title":"Incorporation of thrombin cleavage peptide into a protein cage for constructing a protease-responsive multifunctional delivery nanoplatform","volume":"13","author":"Kang","year":"2012","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2016.08.010_bb0055","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1039\/C4NR00915K","article-title":"Functionalization of protein-based nanocages for drug delivery applications","volume":"6","author":"Schoonen","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2016.08.010_bb0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.phrs.2016.03.002","article-title":"Ferritin nanocages: a biological platform for drug delivery, imaging and theranostics in cancer","volume":"107","author":"Truffi","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2016.08.010_bb0065","doi-asserted-by":"crossref","first-page":"10879","DOI":"10.1021\/nn404325t","article-title":"Proteinticle engineering for accurate 3D diagnosis","volume":"7","author":"Lee","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.08.010_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2016.03.002","article-title":"Bioengineered protein-based nanocage for drug delivery","author":"Lee","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.08.010_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2016.05.006","article-title":"Comparison of two endogenous delivery agents in cancer therapy: exosomes and ferritin","author":"Li","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2016.08.010_bb0080","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/adma.200801209","article-title":"Intracellular distribution of macrophage targeting ferritin-iron oxide nanocomposite","volume":"21","author":"Uchida","year":"2009","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2016.08.010_bb0085","doi-asserted-by":"crossref","first-page":"9196","DOI":"10.1158\/0008-5472.CAN-06-1728","article-title":"Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe","volume":"66","author":"Crich","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2016.08.010_bb0090","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1021\/nl104141g","article-title":"Chimeric ferritin nanocages for multiple function loading and multimodal imaging","volume":"11","author":"Lin","year":"2011","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2016.08.010_bb0095","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1021\/nn500454n","article-title":"A smart platform for hyperthermia application in cancer treatment: cobalt-doped ferrite nanoparticles mineralized in human ferritin cages","volume":"8","author":"Fantechi","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.08.010_bb0100","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1039\/C3TB20081G","article-title":"Bio-inspired protein-gold nanoconstruct with core-void-shell structure: beyond a chemo drug carrier","volume":"1","author":"Liu","year":"2013","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2016.08.010_bb0105","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1039\/c0nr01013h","article-title":"Reactions inside nanoscale protein cages","volume":"3","author":"Bode","year":"2011","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2016.08.010_bb0110","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1073\/pnas.0913192107","article-title":"Binding and uptake of H-ferritin are mediated by human transferrin receptor-1","volume":"107","author":"Li","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.08.010_bb0115","article-title":"Improved doxorubicin encapsulation and pharmacokinetics of ferritin-fusion protein nanocarriers bearing proline, serine, and alanine elements","author":"Falvo","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2016.08.010_bb0120","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/protein\/gzt023","article-title":"PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins","volume":"26","author":"Schlapschy","year":"2013","journal-title":"Protein Eng. Des. Sel."},{"issue":"2003","key":"10.1016\/j.jconrel.2016.08.010_bb0125","first-page":"551","article-title":"Matrix metalloproteinases, angiogenesis, and cancer: commentary re: A. C. Lockhart et al., reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor. Clin. Cancer Res., 9: 00-00","volume":"9","author":"Rundhaug","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2016.08.010_bb0130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/wnan.1221","article-title":"Human ferritin for tumor detection and therapy","volume":"5","author":"Fan","year":"2013","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2016.08.010_bb0135","first-page":"1613","article-title":"Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage","volume":"7","author":"Shi","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2016.08.010_bb0140","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/adhm.201500226","article-title":"H-chain ferritin: a natural nuclei targeting and bioactive delivery nanovector","volume":"4","author":"Zhang","year":"2015","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2016.08.010_bb0145","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1023\/A:1011018525121","article-title":"Differences in the intracellular distribution of acid-sensitive doxorubicin-protein conjugates in comparison to free and liposomal formulated doxorubicin as shown by confocal microscopy. (vol 18, pg 29, 2001)","volume":"18","author":"Beyer","year":"2001","journal-title":"Pharm. Res.-Dordr."},{"key":"10.1016\/j.jconrel.2016.08.010_bb0150","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00428-004-1053-x","article-title":"A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile","volume":"445","author":"Monti","year":"2004","journal-title":"Virchows Arch."},{"key":"10.1016\/j.jconrel.2016.08.010_bb0155","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijpharm.2012.11.003","article-title":"Evaluation of combination therapy schedules of doxorubicin and an acid-sensitive albumin-binding prodrug of doxorubicin in the MIA PaCa-2 pancreatic xenograft model","volume":"441","author":"Kratz","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.08.010_bb0160","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s10637-011-9686-5","article-title":"Combination therapy with the albumin-binding prodrug of doxorubicin (INNO-206) and doxorubicin achieves complete remissions and improves tolerability in an ovarian A2780 xenograft model","volume":"30","author":"Kratz","year":"2012","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.jconrel.2016.08.010_bb0165","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1158\/1078-0432.CCR-06-2776","article-title":"Phase I and pharmacokinetic study of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin","volume":"13","author":"Unger","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2016.08.010_bb0170","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/264542a0","article-title":"Predicting the course of Gompertzian growth","volume":"264","author":"Norton","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2016.08.010_bb0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.colsurfb.2013.07.036","article-title":"Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane(R)","volume":"113","author":"Bernabeu","year":"2014","journal-title":"Colloids Surf. B: Biointerfaces"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916305120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916305120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T03:27:17Z","timestamp":1536463637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916305120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":35,"alternative-id":["S0168365916305120"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.08.010","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}